These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 39048301)
21. Epidemiological and Genetic Characteristics of Respiratory Viral Coinfections with Different Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Trifonova I; Korsun N; Madzharova I; Alexiev I; Ivanov I; Levterova V; Grigorova L; Stoikov I; Donchev D; Christova I Viruses; 2024 Jun; 16(6):. PubMed ID: 38932250 [TBL] [Abstract][Full Text] [Related]
22. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge. Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195 [TBL] [Abstract][Full Text] [Related]
23. Prevailing genotype distribution and characteristics of human respiratory syncytial virus in northeastern China. Zheng Y; Liu L; Wang S; Li Z; Hou M; Li J; Yu XF; Zhang W; Hua S J Med Virol; 2017 Feb; 89(2):222-233. PubMed ID: 27448044 [TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of circulating respiratory syncytial virus genotypes in Pakistani children, 2010-2013. Aamir UB; Salman M; Nisar N; Badar N; Alam MM; Ansari J; Zaidi SSZ J Infect Public Health; 2020 Mar; 13(3):438-445. PubMed ID: 31229412 [TBL] [Abstract][Full Text] [Related]
25. Circulating Respiratory Syncytial Virus Genotypes and Genetic Variability of the G Gene during 2017 and 2018/2019 Seasonal Epidemics Isolated from Children with Lower Respiratory Tract Infections in Daejeon, Korea. Kang HM; Park KC; Park J; Kil HR; Yang EA J Korean Med Sci; 2020 Dec; 35(49):e422. PubMed ID: 33350185 [TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of human respiratory syncytial virus in Seoul, South Korea, during 10 consecutive years, 2010-2019. Kim HN; Hwang J; Yoon SY; Lim CS; Cho Y; Lee CK; Nam MH PLoS One; 2023; 18(4):e0283873. PubMed ID: 37023101 [TBL] [Abstract][Full Text] [Related]
27. Genomic Evolution and Surveillance of Respiratory Syncytial Virus during the 2023-2024 Season. Yunker M; Fall A; Norton JM; Abdullah O; Villafuerte DA; Pekosz A; Klein E; Mostafa HH Viruses; 2024 Jul; 16(7):. PubMed ID: 39066284 [TBL] [Abstract][Full Text] [Related]
28. Genetic characterization of respiratory syncytial virus highlights a new BA genotype and emergence of the ON1 genotype in Lyon, France, between 2010 and 2014. Gaymard A; Bouscambert-Duchamp M; Pichon M; Frobert E; Vallee J; Lina B; Casalegno JS; Morfin F J Clin Virol; 2018 May; 102():12-18. PubMed ID: 29471266 [TBL] [Abstract][Full Text] [Related]
29. Co-Circulation of 72bp Duplication Group A and 60bp Duplication Group B Respiratory Syncytial Virus (RSV) Strains in Riyadh, Saudi Arabia during 2014. Ahmed A; Haider SH; Parveen S; Arshad M; Alsenaidy HA; Baaboud AO; Mobaireek KF; AlSaadi MM; Alsenaidy AM; Sullender W PLoS One; 2016; 11(11):e0166145. PubMed ID: 27835664 [TBL] [Abstract][Full Text] [Related]
30. Spread and clinical severity of respiratory syncytial virus A genotype ON1 in Germany, 2011-2017. Streng A; Goettler D; Haerlein M; Lehmann L; Ulrich K; Prifert C; Krempl C; Weißbrich B; Liese JG BMC Infect Dis; 2019 Jul; 19(1):613. PubMed ID: 31299924 [TBL] [Abstract][Full Text] [Related]
31. Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV). Bergeron HC; Tripp RA Expert Opin Investig Drugs; 2022 Jan; 31(1):23-29. PubMed ID: 34937485 [TBL] [Abstract][Full Text] [Related]
33. Whole genome sequencing and evolutionary analysis of human respiratory syncytial virus A and B from Milwaukee, WI 1998-2010. Rebuffo-Scheer C; Bose M; He J; Khaja S; Ulatowski M; Beck ET; Fan J; Kumar S; Nelson MI; Henrickson KJ PLoS One; 2011; 6(10):e25468. PubMed ID: 21998661 [TBL] [Abstract][Full Text] [Related]
34. Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data. Wilkins D; Langedijk AC; Lebbink RJ; Morehouse C; Abram ME; Ahani B; Aksyuk AA; Baraldi E; Brady T; Chen AT; Chi H; Choi EH; Cohen R; Danilenko DM; Gopalakrishnan V; Greenough A; Heikkinen T; Hosoya M; Keller C; Kelly EJ; Kragten-Tabatabaie L; Martinón-Torres F; de Los Santos AHM; Nunes MC; Palomino MA; Papenburg J; Pernica JM; Richmond P; Stein RT; Tuffy KM; Verwey C; Esser MT; Tabor DE; Bont LJ; Lancet Infect Dis; 2023 Jul; 23(7):856-866. PubMed ID: 36940703 [TBL] [Abstract][Full Text] [Related]
35. A systematic review on global RSV genetic data: Identification of knowledge gaps. Langedijk AC; Harding ER; Konya B; Vrancken B; Lebbink RJ; Evers A; Willemsen J; Lemey P; Bont LJ Rev Med Virol; 2022 May; 32(3):e2284. PubMed ID: 34543489 [TBL] [Abstract][Full Text] [Related]
36. Within-host whole-genome deep sequencing and diversity analysis of human respiratory syncytial virus infection reveals dynamics of genomic diversity in the absence and presence of immune pressure. Grad YH; Newman R; Zody M; Yang X; Murphy R; Qu J; Malboeuf CM; Levin JZ; Lipsitch M; DeVincenzo J J Virol; 2014 Jul; 88(13):7286-93. PubMed ID: 24741088 [TBL] [Abstract][Full Text] [Related]
37. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol. Mallah N; Ares-Gómez S; Pardo-Seco J; Malvar-Pintos A; Santiago-Pérez MI; Pérez-Martínez O; Otero-Barrós MT; Suárez-Gaiche N; Kramer R; Jin J; Platero-Alonso L; Alvárez-Gil RM; Ces-Ozores OM; Nartallo-Penas V; Mirás-Carballal S; Piñeiro-Sotelo M; González-Pérez JM; Rodríguez-Tenreiro C; Rivero-Calle I; Salas A; Durán-Parrondo C; Martinón-Torres F Hum Vaccin Immunother; 2024 Dec; 20(1):2348135. PubMed ID: 38738683 [TBL] [Abstract][Full Text] [Related]
38. Circulation of new lineages of RSV-A and RSV-B in Kuwait shows high diversity in the N- and O-linked glycosylation sites in the G protein between 2020 and 2022. Madi N; Sadeq M; Safar HA; Al-Adwani A; Al-Turab M Front Cell Infect Microbiol; 2024; 14():1445115. PubMed ID: 39220282 [TBL] [Abstract][Full Text] [Related]
39. Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants. DeVincenzo JP; Hall CB; Kimberlin DW; Sánchez PJ; Rodriguez WJ; Jantausch BA; Corey L; Kahn JS; Englund JA; Suzich JA; Palmer-Hill FJ; Branco L; Johnson S; Patel NK; Piazza FM J Infect Dis; 2004 Sep; 190(5):975-8. PubMed ID: 15295704 [TBL] [Abstract][Full Text] [Related]
40. Characterization of human respiratory syncytial virus (RSV) isolated from HIV-exposed-uninfected and HIV-unexposed infants in South Africa during 2015-2017. Liu H; Lu B; Tabor DE; Tovchigrechko A; Wilkins D; Jin H; Madhi SA; Soofie N; Esser MT; Nunes MC Influenza Other Respir Viruses; 2020 Jul; 14(4):403-411. PubMed ID: 32126161 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]